AU2023265523A1 - Substituted imidazopyridines and imidazopyrimidines, and use of same for treating, ameliorating, and/or preventing retinal degeneration - Google Patents
Substituted imidazopyridines and imidazopyrimidines, and use of same for treating, ameliorating, and/or preventing retinal degeneration Download PDFInfo
- Publication number
- AU2023265523A1 AU2023265523A1 AU2023265523A AU2023265523A AU2023265523A1 AU 2023265523 A1 AU2023265523 A1 AU 2023265523A1 AU 2023265523 A AU2023265523 A AU 2023265523A AU 2023265523 A AU2023265523 A AU 2023265523A AU 2023265523 A1 AU2023265523 A1 AU 2023265523A1
- Authority
- AU
- Australia
- Prior art keywords
- compound
- certain embodiments
- subject
- group
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263338264P | 2022-05-04 | 2022-05-04 | |
| US63/338,264 | 2022-05-04 | ||
| US202263411405P | 2022-09-29 | 2022-09-29 | |
| US63/411,405 | 2022-09-29 | ||
| PCT/US2023/020978 WO2023215465A1 (en) | 2022-05-04 | 2023-05-04 | Substituted imidazopyridines and imidazopyrimidines, and use of same for treating, ameliorating, and/or preventing retinal degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2023265523A1 true AU2023265523A1 (en) | 2024-11-21 |
Family
ID=88647025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2023265523A Pending AU2023265523A1 (en) | 2022-05-04 | 2023-05-04 | Substituted imidazopyridines and imidazopyrimidines, and use of same for treating, ameliorating, and/or preventing retinal degeneration |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250288588A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4519268A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025516315A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119487033A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023265523A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3251997A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023215465A1 (cg-RX-API-DMAC7.html) |
-
2023
- 2023-05-04 EP EP23800027.7A patent/EP4519268A1/en active Pending
- 2023-05-04 AU AU2023265523A patent/AU2023265523A1/en active Pending
- 2023-05-04 JP JP2024564932A patent/JP2025516315A/ja active Pending
- 2023-05-04 CA CA3251997A patent/CA3251997A1/en active Pending
- 2023-05-04 CN CN202380050874.5A patent/CN119487033A/zh active Pending
- 2023-05-04 WO PCT/US2023/020978 patent/WO2023215465A1/en not_active Ceased
- 2023-05-04 US US18/862,727 patent/US20250288588A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4519268A1 (en) | 2025-03-12 |
| JP2025516315A (ja) | 2025-05-27 |
| WO2023215465A1 (en) | 2023-11-09 |
| US20250288588A1 (en) | 2025-09-18 |
| CA3251997A1 (en) | 2023-11-09 |
| CN119487033A (zh) | 2025-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6602802B2 (ja) | Ssaoの置換3−ハロアリルアミン阻害剤およびその使用 | |
| US7087645B2 (en) | Compounds and methods for treating transplant rejection | |
| US10526297B2 (en) | Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases | |
| US11858910B2 (en) | Pyridinylmethylenepiperidine derivatives and uses thereof | |
| US20030134802A1 (en) | Novel effectors of dipepetidyl peptidase IV | |
| IL126836A (en) | Beta-inhibitor of protein kinase C beta-use for use as a drug for the treatment of eye diseases | |
| CN115768419A (zh) | 用于色满卡林前药治疗的改进方法和组合物 | |
| CA3145738A1 (en) | Difluorohaloallylamine sulfone derivative inhibitors of lysyl oxidases, methods of preparation, and uses thereof | |
| US20230017597A1 (en) | 8-substituted styryl xanthine derivatives and uses thereof | |
| US20250288588A1 (en) | Substituted imidazopyridines and imidazopyrimidines, and use of same for treating, ameliorating, and/or preventing retinal degeneration | |
| US20250222115A1 (en) | Drug Conjugates of Sugar Derivatives and Uses Thereof as Senolytic Agents | |
| US20150197536A1 (en) | Compounds reducing the production of sorbitol in the eye and methods of using the same | |
| EP4229058B1 (en) | Substituted 4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)thiophene-2-carboxamide derivatives and use thereof | |
| WO2025199211A1 (en) | Imidazopyridines and imidazopyrimidines, and methods of using same | |
| US20210206773A1 (en) | Drug for treating disorders of corneal epithelium | |
| KR101799429B1 (ko) | 신경 세포 사멸 또는 신경 퇴화를 억제하기 위한 약학적 조성물 | |
| KR101896398B1 (ko) | 신경 세포 사멸 또는 신경 퇴화를 억제하기 위한 약학적 조성물 | |
| US12310970B2 (en) | Compounds and methods for treating or preventing anterior segment ocular disorders and/or retinal degenerations | |
| US9856230B2 (en) | Enzyme inhibitors | |
| JP2005529160A (ja) | 糖尿病及び糖尿病−関連障害の処置のための化合物及び組成物 | |
| HK40093954A (en) | Substituted 4‑([1,2,4]triazolo[1,5‑a]pyridin‑6‑yl)thiophene‑2‑carboxamide derivatives and use thereof | |
| CN118591529A (zh) | 氘代rock抑制剂、药物组合物和治疗应用 | |
| WO2024044813A1 (en) | Novel selective inhibitors of lysyl oxidases | |
| CN121270631A (zh) | 含一氧化氮供体的化合物 | |
| CN108864033A (zh) | 苯基取代的酰肼衍生物及其用途 |